帕金森病丘脑底核与苍白球内侧部脑深部电刺激综述
本综述比较丘脑底核(STN)与苍白球内侧部(GPi)脑深部电刺激(DBS)治疗帕金森病运动并发症的随机临床试验证据。两者运动获益相似,但STN在减少多巴胺能药物方面更一致,GPi在抑制异动症方面可能更优。靶点选择应个体化,结合患者临床表现、神经精神状况和手术目标。
要点
- STN与GPi DBS对帕金森病运动症状的改善程度相似。
- STN DBS减少多巴胺能药物更一致,GPi DBS抑制异动症可能更优。
- 靶点选择需结合患者临床表现、神经精神状况和手术目标个体化。
核心结论
- GPi和STN DBS均提供相似、一致且显著的运动获益,但靶点间存在细微差异。
- 靶点选择应个体化,结合患者临床表现、神经精神状况和手术目标。
研究设计与样本
- 本综述汇总随机临床试验证据,比较STN与GPi DBS治疗帕金森病运动并发症。
主要发现
- 随机临床试验证据增加表明两者运动获益相似,包括对异动症的影响和生活质量改善。
- STN DBS一致地更大程度减少多巴胺能药物,可能在非运动领域有轻度获益,并可能具有经济优势。
- GPi DBS在抑制异动症、单侧电极管理症状以及药物和程控调整灵活性方面可能有优势。
- 总体而言,STN DBS相比GPi DBS的神经精神变化风险可能更高或相当。
临床怎么用
- 靶点选择应基于患者临床表现、神经精神状况和手术目标进行个体化定制。
- STN DBS可能适合需要减少多巴胺能药物或考虑经济因素的患者。
- GPi DBS可能适合需要抑制异动症、单侧电极管理或药物程控灵活性高的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Selection of the best deep brain stimulation (DBS) target-subthalamic nucleus (STN) or globus pallidus interna (GPi)-for treatment of motor complications in Parkinson disease remains a matter of debate. OBSERVATIONS: Increasing evidence from randomized clinical trials indicates that motor benefit is similar between both targets, including an effect on dyskinesia and improvement in quality of life. Deep brain stimulation of the STN offers consistently greater dopaminergic medication reduction, possible mild benefit in nonmotor domains, and potential economic advantage. Deep brain stimulation of the GPi provides a probable advantage in dyskinesia suppression, management of symptoms with unilateral leads, and flexibility in medications and programming adjustments. Overall, STN DBS is at potentially higher or equal risk for neuropsychiatric changes compared with GPi DBS. CONCLUSIONS AND RELEVANCE: Both GPi and STN DBS provide similar, consistent, marked motor benefits, but subtle target differences exist. Target selection should be tailored to each patient's clinical presentation, neuropsychiatric profile, and goals of surgery, allowing customization of this therapy and improved individual outcomes.
引用
- Ramirez-Zamora A, Ostrem JL. Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease: A Review. JAMA Neurol. 2018. PMID: 29356826. doi:10.1001/jamaneurol.2017.4321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。